$REE

REE Automotive Announces a Supplement to its Proxy Statement for its Special General Meeting of Shareholders to be held on November 13, 2025

TEL AVIV, Israel, Nov. 11, 2025 ( GLOBE NEWSWIRE ) -- REE Automotive Ltd. ( Nasdaq: REE ) ( "REE" ) , an automotive technology company developing software-defined vehicle technology, today announced the release of a supplement ( the "Supplement" ) to its proxy statement dated October 9, 2025 ( ...

Original reporting
GlobeNewswire · REE Automotive Ltd.
Published Nov 11, 2025, 10:45 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 11, 2025, 11:01 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
REE Automotive Announces a Supplement to its Proxy Statement for its Special General Meeting of Shareholders to be held on November 13, 2025 — source image
Decision brief

The 30-second read

$REEBullishMed
01

Why it matters

The supplement to the proxy statement suggests active shareholder engagement, which may be viewed positively by investors.

02

Market read

The news is relevant primarily to investors in automotive technology and related sectors, with a focus on corporate governance developments.

03

What to watch

Potential delays or negative developments in the shareholder meeting could negate gains; broader market volatility may also influence stock performance.

Relevance 6/10Timing: High, as the shareholder meeting is scheduled for November 13, 2025, with the supplement released shortly before.

Background

REE Automotive is developing software-defined vehicle technology, with recent corporate governance activities indicating ongoing strategic initiatives.

Company-level read

Ticker impact

$REEBullishHigh confidence
Context

Primary focus due to recent news and positive sentiment.

Expected impact

Moderate upward movement expected within the next 1-2 weeks, approximately 3-5% increase.

Evidence & confidence

The bullish sentiment score (0.438) combined with positive industry relevance and recent corporate activity support a favorable outlook.

Market effects

Potential positive impact on automotive technology sector, especially companies involved in software-defined vehicle development.

Limited regional impact, primarily affecting Israeli and U.S. markets where REE is listed.

Moderate, as REE's activities are of interest to global automotive investors.

Counterpoint

The positive sentiment may already be priced in, and the announcement could be a routine update with limited impact.

Key entities

  • REE Automotive Ltd.

    An automotive technology company specializing in software-defined vehicles.

Related articles

$CEROHighAI 8/10

Delisting of Securities from The Nasdaq Stock Market

Nasdaq said it will delist multiple issuers’ securities from the Nasdaq Stock Market, including CERo Therapeutics Holdings, Bowen Acquisition Corp, Graphjet Technology, Blue Hat Interactive Entertainment Technology, X3 Holdings Co, Captivision Inc, Actelis Networks, American Rebel Holdings, Reviva Pharmaceuticals, Alchemy Investments Acquisition Corp 1, Bitcoin Depot, Inotiv, GoHealth, Functional Brands, Sleep Number, Smart Digital Group, and REE Automotive. Most were suspended in 2025-2026 and

$FWRDMed

Forward Air Announces Two-Year Definitive Agreement to Retain Significant Portion of Previously Disclosed Customer Relationship

FORWARD AIR CORP (FWRD) filed an SEC Form 8-K — Other Events. Forward Air Announces Two-Year Definitive Agreement to Retain Significant Portion of Previously Disclosed Customer Relationship 2026 to 2028 Forecasted Annual Revenue from Customer Expected to Exceed 2025 Revenue Driven by Growth in Retained Services DALLAS – October 28, 2026 – F

$PYPDMedAI 8/10

PolyPid unveils PD01B for diabetic foot infection treatment

PolyPid Ltd. (NASDAQ:PYPD) introduced PD01B, a product candidate for treating moderate to severe diabetic foot infections, using its Kynatrix delivery technology. The company plans to initiate a first-in-human study in the second half of 2027. PolyPid also expects a decision on its lead product D-PLEX₁₀₀ by November 28, 2026, with a potential U.S. launch in early 2027, subject to FDA approval.

$KTOSMed

Kratos wins $33.6 million NASA power system contract

Kratos Defense & Security Solutions (KTOS) won a $33.6M contract from NASA to design and build a power system for the Space Reactor-1 Freedom spacecraft, launching in 2028. Kratos will work as a subcontractor to Sierra Lobo under NASA’s SpaceDOC III contract, providing a power conversion system for the mission to Mars. The spacecraft aims to demonstrate nuclear electric propulsion technology. According to the company, the contract is a significant milestone in advancing space nuclear propulsion.